about
Medication errors related to transdermal opioid patches: lessons from a regional incident reporting systemThe Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event.A systematic review of medication administration errors with transdermal patches.Formulation design for topical drug and nanoparticle treatment of skin disease.Proniosomes derived niosomes: recent advancements in drug delivery and targeting.An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine.Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis.Transdermal patches: how common are application site reactions and how severe are they?
P2860
Q33773016-15847D8F-B986-4A8E-B4A2-B16937E3D0E0Q35918233-4D21E2BF-4458-4A15-A978-60F33CAF6A42Q38219672-D38E571D-B918-4249-9138-F97667BBF562Q38358872-D97AB179-46FC-4BE9-8AEB-97DB44D25380Q47355869-907120D2-4D73-4939-BD36-1767269963A5Q50328399-39B57973-E82D-4C66-A6FC-E893A97053D6Q53114049-A8E5D4B9-A017-4B2C-8401-1E26ECB388ABQ56790653-507B1979-EE0A-47EC-964F-BB92E6EF0E91
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Skin tolerability of transdermal patches.
@ast
Skin tolerability of transdermal patches.
@en
type
label
Skin tolerability of transdermal patches.
@ast
Skin tolerability of transdermal patches.
@en
prefLabel
Skin tolerability of transdermal patches.
@ast
Skin tolerability of transdermal patches.
@en
P2093
P2860
P1476
Skin tolerability of transdermal patches.
@en
P2093
Johannes Wohlrab
P2860
P304
P356
10.1517/17425247.2011.574689
P407
P577
2011-04-21T00:00:00Z